Cargando…

Fas Apoptosis Inhibitory Molecule Blocks and Dissolves Pathological Amyloid-β Species

A number of neurodegenerative diseases are associated with the accumulation of misfolded proteins, including Alzheimer’s disease (AD). In AD, misfolded proteins such as tau and amyloid-β (Aβ) form pathological insoluble deposits. It is hypothesized that molecules capable of dissolving such protein a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaku, Hiroaki, Ludlow, Alexander V., Gutknecht, Michael F., Rothstein, Thomas L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712662/
https://www.ncbi.nlm.nih.gov/pubmed/34970117
http://dx.doi.org/10.3389/fnmol.2021.750578
_version_ 1784623601864933376
author Kaku, Hiroaki
Ludlow, Alexander V.
Gutknecht, Michael F.
Rothstein, Thomas L.
author_facet Kaku, Hiroaki
Ludlow, Alexander V.
Gutknecht, Michael F.
Rothstein, Thomas L.
author_sort Kaku, Hiroaki
collection PubMed
description A number of neurodegenerative diseases are associated with the accumulation of misfolded proteins, including Alzheimer’s disease (AD). In AD, misfolded proteins such as tau and amyloid-β (Aβ) form pathological insoluble deposits. It is hypothesized that molecules capable of dissolving such protein aggregates might reverse disease progression and improve the lives of afflicted AD patients. Here we report new functions of the highly conserved mammalian protein, Fas Apoptosis Inhibitory Molecule (FAIM). We found that FAIM-deficient Neuro 2A cells accumulate Aβ oligomers/fibrils. We further found that recombinant human FAIM prevents the generation of pathologic Aβ oligomers and fibrils in a cell-free system, suggesting that FAIM functions without any additional cellular components. More importantly, recombinant human FAIM disaggregates and solubilizes established Aβ fibrils. Our results identify a previously unknown, completely novel candidate for understanding and treating irremediable, irreversible, and unrelenting neurodegenerative diseases.
format Online
Article
Text
id pubmed-8712662
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-87126622021-12-29 Fas Apoptosis Inhibitory Molecule Blocks and Dissolves Pathological Amyloid-β Species Kaku, Hiroaki Ludlow, Alexander V. Gutknecht, Michael F. Rothstein, Thomas L. Front Mol Neurosci Neuroscience A number of neurodegenerative diseases are associated with the accumulation of misfolded proteins, including Alzheimer’s disease (AD). In AD, misfolded proteins such as tau and amyloid-β (Aβ) form pathological insoluble deposits. It is hypothesized that molecules capable of dissolving such protein aggregates might reverse disease progression and improve the lives of afflicted AD patients. Here we report new functions of the highly conserved mammalian protein, Fas Apoptosis Inhibitory Molecule (FAIM). We found that FAIM-deficient Neuro 2A cells accumulate Aβ oligomers/fibrils. We further found that recombinant human FAIM prevents the generation of pathologic Aβ oligomers and fibrils in a cell-free system, suggesting that FAIM functions without any additional cellular components. More importantly, recombinant human FAIM disaggregates and solubilizes established Aβ fibrils. Our results identify a previously unknown, completely novel candidate for understanding and treating irremediable, irreversible, and unrelenting neurodegenerative diseases. Frontiers Media S.A. 2021-12-14 /pmc/articles/PMC8712662/ /pubmed/34970117 http://dx.doi.org/10.3389/fnmol.2021.750578 Text en Copyright © 2021 Kaku, Ludlow, Gutknecht and Rothstein. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Kaku, Hiroaki
Ludlow, Alexander V.
Gutknecht, Michael F.
Rothstein, Thomas L.
Fas Apoptosis Inhibitory Molecule Blocks and Dissolves Pathological Amyloid-β Species
title Fas Apoptosis Inhibitory Molecule Blocks and Dissolves Pathological Amyloid-β Species
title_full Fas Apoptosis Inhibitory Molecule Blocks and Dissolves Pathological Amyloid-β Species
title_fullStr Fas Apoptosis Inhibitory Molecule Blocks and Dissolves Pathological Amyloid-β Species
title_full_unstemmed Fas Apoptosis Inhibitory Molecule Blocks and Dissolves Pathological Amyloid-β Species
title_short Fas Apoptosis Inhibitory Molecule Blocks and Dissolves Pathological Amyloid-β Species
title_sort fas apoptosis inhibitory molecule blocks and dissolves pathological amyloid-β species
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712662/
https://www.ncbi.nlm.nih.gov/pubmed/34970117
http://dx.doi.org/10.3389/fnmol.2021.750578
work_keys_str_mv AT kakuhiroaki fasapoptosisinhibitorymoleculeblocksanddissolvespathologicalamyloidbspecies
AT ludlowalexanderv fasapoptosisinhibitorymoleculeblocksanddissolvespathologicalamyloidbspecies
AT gutknechtmichaelf fasapoptosisinhibitorymoleculeblocksanddissolvespathologicalamyloidbspecies
AT rothsteinthomasl fasapoptosisinhibitorymoleculeblocksanddissolvespathologicalamyloidbspecies